Shilpa Medicare has launched its generic version of cancer drug Dasatinib at a monthly therapy cost of Rs 6,440.
Daily Current Affairs Quiz 2020
Key-Points
Dasashil, the branded generic anti-cancer drug, will be available in all dosage strengths of 20 mg, 50 mg, 70 mg, and 100 mg tablets.
The drug is used for the treatment of Chronic Myeloid Leukaemia (CML).
Dasashil will revolutionize the treatment by ensuring to make therapy available for more Indian patients due to increased affordability.
The products are being manufactured and supplied from the company’s US Food and Drug Administration (FDA) approved manufacturing facility.
The drug can benefit around 10,000 to 15,000 new patients of CML in India.
